Cariprazine Hydrochloride
CAS 1083076-69-0 14 FDA-DMF suppliersSmall Molecule
Overview
Cariprazine Hydrochloride is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. It acts as a partial agonist at D2 and D3 dopamine receptors, providing therapeutic effects on both positive and negative symptoms.
API suppliers (1)
Suppliers of Cariprazine Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Gedeon RichterHungary1 active DMF
Therapeutic areas
PsychiatryBipolar DisorderSchizophrenia
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.